Asian Journal of Endoscopic Surgery

Cover image for Vol. 7 Issue 3

Edited By: Masaki Kitajima

Online ISSN: 1758-5910



Author Guidelines


Thank you for your interest in the Asian Journal of Endoscopic Surgery. Please take a moment to consult the following instructions to help you prepare your manuscript, and feel free to contact us with any questions. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.

CONTENTS
1. About the Journal
2. Editorial Review and Acceptance
3. Manuscript Categories
4. Disclosure
5. Ethical Considerations
6. Clinical Trials Registry
7. Randomized Controlled Trials
8. Copyright
9. Style of Manuscripts
10. Structure of Manuscripts
11. Supporting Information
12. Submission of Manuscripts
13. Proofs
14. Offprints
15. Color Fee
16. Tracking Manuscripts
17. EarlyView
18. The Journal Online
19. Editorial Office

1. ABOUT THE JOURNAL
Scope: Asian Journal of Endoscopic Surgery, a joint official journal of the Japan Society for Endoscopic Surgery, Endoscopic and Laparoscopic Surgeons of Asia, and the Asia Endosurgery Task Force publishes significant studies in the fields of endoscopic surgery. The Journal welcomes Original Articles, Case Reports, Surgical Techniques, My Approach, and Short Reports, which are peer-reviewed by the editorial board. Letters to the Editor commenting on articles published in the journal or expressing views on topics concerning surgery are also welcomed. Special articles, including Review Articles are provided by the Editorial Board and invited authors. Meeting Reports include summaries of symposia or consensus achieved in the congresses of related associations.

Editor: Masaki Kitajima
Frequency: 4 issues per year
ISSN: 1758-5902 (print), 1758-5910 (online)
Abstracting & Indexing Service: MEDLINE (accepted in 2011)
Journal abbreviation: Asian J Endosc Surg
Publisher: Wiley Publishing Asia Pty Ltd

2. EDITORIAL REVIEW AND ACCEPTANCE
Before peer review: Your contribution must be your own original work, which will contribute to the progress of endoscopic surgery, and must not have been published elsewhere. Your contribution must be accompanied your signed copyright form, a statement that your contribution has not been published elsewhere, and is not being peer reviewed elsewhere.

Acceptance:
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. The Editorial Board reserves the right to refuse any material for publication and advises that authors should retain copies of submitted manuscripts and correspondence as material cannot be returned. Final acceptance or rejection rests with the Editorial Board.

All manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of endoscopic content, the Editor and the Publisher reserve the right to modify manuscripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.

3. MANUSCRIPT CATEGORIES
(1) ORIGINAL ARTICLE
Word limit: 3,750 words including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, structured (sub-headers): Introduction, Methods, Results, Conclusion.
References: Up to 50 in total.
Description: Full-length reports of current research in either basic or clinical science. Arrange text as follows: Abstract; Introduction; Materials and Methods; Results; Discussion; Acknowledgment; References; and when relevant Supporting Information. Video is welcome as Supporting Information.

(2) CASE REPORT
Only cases of exceptional interest and novelty are considered. For manuscripts that do not qualify, Editors may ask authors to shorten manuscripts and rewrite as Letters to the Editor.
Word limit: 1,200 words including abstract but excluding references, tables and figures.
Abstract: 150 words, unstructured (no use of sub-headers).
References: Up to 10 in total.
Figures/tables: Up to 4 in total (1a, 1b,1c are counted as 4 figures not 1 figure).
Description: New observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in endoscopy. Arrange text as follows: Abstract; Introduction; Case Presentation; Discussion; Acknowledgment; References; and when relevant Supporting Information. Video is welcome as Supporting Information.

(3) SURGICAL TECHNIQUE
Word limit: 1,200 words including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, structured (sub-headers): Introduction; Materials and Surgical Technique; Discussion.
References: Up to 20 in total.
Figures/tables: Up to 4 in total.
Description: Outlines particular techniques. Arrange text as follows: Abstract; Introduction; Materials and Surgical Technique; Discussion; Acknowledgment; References; and when relevant Supporting Information. Video is particularly welcome as Supporting Information.

(4) MY APPROACH
Word limit: 700 words including abstract but excluding references, tables and figures.
Abstract: 150 words, unstructured (no use of sub-headers).
References: Up to 10 in total.
Figures/tables: Up to 4 in total.
Description: Should focus on explaining the instruments or appliances developed independently by the author(s) in the following structure: Abstract; Introduction; Case Presentation; Discussion; Acknowledgment; References; and when relevant Supporting Information. Video is welcome as Supporting Information.

(5) SHORT REPORT
Word limit: 1,500 words including abstract but excluding references, tables and figures.
Abstract: 150 words, unstructured (no use of sub-headers).
References: Up to 35 in total.
Figures/tables: Up to 4 in total.
Description: New findings that will substantially and immediately affect research or clinical practice. Arrange text as follows: Abstract; Introduction; Case Presentation (Materials and Methods OR Materials and Surgical Techniques); Results; Discussion; Acknowledgment; References; and when relevant Supporting Information. Video is welcome as Supporting Information.

(6) LETTERS TO THE EDITOR
Word limit: 500 words.
Authors: Maximum three authors.
Abstract: No abstract.
References: Up to 4 in total.
Figures/tables: Up to 1 (multi panel figures allowed).
Description: Letters may be submitted to the Editor on any topic of discussion; clinical observations as well as letters commenting on papers published in recent issues. Letter to the Editor are not subjected to peer-review. Submissions maybe edited for length, grammatical correctness, and journal style. Authors will be asked to approve editorial changes that alter the substance or tone of a letter or response. Letters that offer perspective on content already published in the Journal can use an arbitrary title, but a Response from authors must cite the title of the first letter:  e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.
 
(7) REVIEW ARTICLE
[BY INVITATION OR AFTER PROPOSAL OUTLINE]
Word limit: 5,000 words including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, structured or unstructured.
References: Up to 80 in total.
Figures/tables: Minimum 1 image or figure.
Description: Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editor. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

(8) EDITORIAL
[BY INVITATION OR AFTER PROPOSAL OUTLINE]
Word limit: 1,600 words.
Abstract: No abstract.
References: Up to 5 in total.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

(9) GUIDELINE
Word limit: The final paper should within 13 typeset pages including tables, figures and references (i.e. 1 average page incl. figures and tables: 800words).
Abstract: 250 words, unstructured (no use of sub-headers).
References: Up to 100 in total. All references must be collated at the end of the text.
Description: Statements designed to help clinicians make decisions about appropriate diagnosis and treatment for specific circumstances.

(10) MEETING REPORT
[BY INVITATION OF EDITORS]
Word limit: To be determined in consultation with Editors.
Preface: 250 words, unstructured (no use of sub-headers).
References: No limit.
Description: Meeting Reports include summaries of symposia or consensus achieved in the congresses of related associations. Proposals for these articles may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited articles will undergo peer review prior to acceptance.

4. DISCLOSURE
Authors should declare any financial support or relationships that may pose conflict of interest in the Covering Letter and Acknowledgments.

5. ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Seoul 2008), available at:
http://www.wma.net/en/30publications/10policies/b3/index.html. All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). In general, submission of a case report should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editors recognize that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case. Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.

6. CLINICAL TRIALS REGISTRY
We strongly recommend, as a condition of consideration for publication, registration in a public trials registry. Trials register at or before the onset of patient enrollment. This policy applies to any clinical trial starting enrollment after January 1, 2006. For trials that began enrollment before this date, we request registration by April 1, 2006, before considering the trial for publication. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as studies on pharmacokinetics or major toxicity (e.g., phase 1 trials), are exempt.

We do not advocate one particular registry, but registration are with a registry that meets the following minimum criteria: (1) accessible to the public at no charge; (2) searchable by standard, electronic (Internet-based) methods; (3) open to all prospective registrants free of charge or at minimal cost; (4) validates registered information; (5) identifies trials with a unique number; and (6) includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed) and funding source(s).

Registries that currently meet these criteria include: (1) the registry sponsored by the United States National Library of Medicine (www.clinicaltrials.gov); (2) the International Standard Randomized Controlled Trial Number Registry (http://www.controlled-trials.com/); (3) the Australian Clinical Trials Registry (http://www.actr.org.au/); (4) the Chinese Clinical Trials Register (http://www.chictr.org/); and (5) the Clinical Trials Registry - India (http://www.ctri.in/); (6) University hospital Medical Information Network (UMIN) (http://www.umin.ac.jp/ctr/).

7. RANDOMIZED CONTROLLED TRIALS
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement:
http://www.consort-statement.org/.

8. COPYRIGHT
Papers accepted for publication in the Journal become copyright of Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and the Publisher, and authors will be asked to sign a transfer of copyright form. In signing the transfer of copyright, it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read and agree to the conditions outlined in the Copyright Transfer Agreement, and must sign the Form or agree that the corresponding author can sign on their behalf. Acceptance of a manuscript is contingent upon receipt of a signed Copyright Transfer Agreement, available at the journal submission site under Instructions & Forms, and http://mc.manuscriptcentral.com/societyimages/ases/ASES-CTA-A-Society.pdf.

NIH Public Access Mandate: For those interested in our policy on the NIH Public Access Mandate, please consult our policy statement:
http://www.wiley.com/WileyCDA/Section/id-321171.html.

Note to contributors on deposit of accepted version
Funder arrangements:
Certain funders, including the NIH, members of the Research Councils UK (RCUK) and Wellcome Trust require deposit of the Accepted Version in a repository after an embargo period. Details of funding arrangements are set out at the following website: http://www.wiley.com/go/funderstatement. Please contact the Journal production editor if you have additional funding requirements.
Institutions: Wiley has arrangements with certain academic institutions to permit the deposit of the Accepted Version in the institutional repository after an embargo period. If you do not select the OnlineOpen option you will follow the current licensing signing process as described above.

For authors choosing OnlineOpen: If you decide to select the OnlineOpen option, please use the links below to obtain an Open Access Agreement form to sign. By selecting the OnlineOpen option you have the choice of the following Creative Commons License Open Access Agreements:
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please click the license types above and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html. If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements.

9. STYLE OF MANUSCRIPTS
Manuscripts must follow the style detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at:
http://www.ICMJE.org/.

Spelling: The Journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary. Foreign names and terms, such as names of chemicals should be written in the original language. Proper nouns and German nouns should be capitalized.

Units: All measurements must be given in SI or SI-derived units. For more information about SI units, please go to the Bureau International des Poids et Mesures (BIPM) website at: http://www.bipm.fr/.

Abbreviations: Must be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Trade names: Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

10. STRUCTURE OF MANUSCRIPTS
The length of manuscripts must adhere to the specifications under the section Manuscript Categories. Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments including disclosure, (v) references, (vi) supporting information, (vii) figure legends, (viii) tables (each table complete with title and footnotes) and (ix) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Title Page
The title page should contain (i) manuscript category (ii) the title of the paper, (iii) the full names of the authors and (iv) the addresses of the institutions at which the work was carried out together with (v) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent (vi) a word count.

The present address of any author, if different from that where the work was carried out, should be supplied in a footnote. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author's contribution to the paper is to be quantified. The title should be short, informative and contain the major key words so that readers and in particular online users will discover the article easily in online search. Do not use abbreviations in the title. A short running title (less than 40 characters) should also be provided. The running title is the short title in the upper right hand corner of articles to help article search.

Abstract and Keywords
The length of abstracts must adhere to the specifications under the section Manuscript Categories. Please note that the requirements differ between manuscript types. The abstract should not contain abbreviations or references.

Three key words, for the purposes of indexing and peer review, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at:
http://www.nlm.nih.gov/mesh/meshhome.html.

Text
Please note that the requirements differ between manuscript types. Please refer to Manuscript Categories for individual requirements.

Acknowledgments
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not appropriate.

References
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text. In the reference list up to 3 authors; when four or more, list the first three followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list. Names of journals should be abbreviated in the style used in Index Medicus. Authors are responsible for the accuracy of the references.

Journal articles:
1. Gibas Z, Prout DF Jr, Pontes JR. Chromosome changes in germ cell tumors of the testis. Cancer Genet Cytogenet 1986; 19: 245-252.

Journal articles published ahead of issue (print or online):
2. Benz PJ, Soll J, Bölter B. Protein transport in organelles: The composition, function and regulation of the Tic complex in chloroplast protein import. FEBS Journal 2009. doi: 10.1111/j.1742-4658.2009.06874.x

Books:
3. Ernstoff M. Urologic Cancer. Boston: Blackwell Science, 1997.

Chapter in an edited book:
4. Gilchrist RK. Further commentary: Continent stroma. In: King LR, Stone AR, Webster GD (eds). Bladder Reconstruction and Continent Urinary Diversion. Chicago: Year Book Medical, 1987; 204–205.

Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings. Tables should be submitted in Microsoft word or excel. Image files and groupings of text boxes should be avoided. If tables have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.

Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Magnifications should be indicated using a scale bar on the illustration. If figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.

Size: Figures sizes to fit within the column (80 mm), intermediate (110 mm) or the full text width (166 mm).

Resolution: Figures must be supplied as high resolution saved as .eps (for line drawings) or .tif (for photographs). Halftone figures 300 ppi (pixels per inch), color figures 300 ppi, figures containing text 400 ppi, line figures 1000 ppi.

Line figures: Must be sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package.

Text sizing in figures: Lettering must be included and should be sized to be no larger than the journal text or 8 point (should be readable after reduction – avoid large type or thick lines).

Line width: Between 0.5 and 1 point.

Figure legends: Type figure legends on a separate page. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. More help on preparation of illustrations can be found at: http://authorservices.wiley.com/bauthor/illustration.asp.

Equations
Equations should be numbered sequentially with Arabic numerals; these should be ranged right in parentheses. All variables should appear in italics. Use the simplest possible form for all mathematical symbols.

11. SUPPORTING INFORMATION
Supporting Information is provided by the authors to support the content of an article but they are not integral to that article. They are hosted via a link on Wiley Online Library, but do not appear in the print version of the article. Supporting Information must be submitted together with the article for review; they should not be added at a later stage. They can be in the form of tables, figures, appendices and even video footage. Reference to Supporting Information in the main body of the article is allowed. However, it should be noted that excessive reference to a piece of Supporting Information may indicate that it would be better suited as a proper reference or fully included figure/table. The materials will be published as they are supplied and will not be checked or typeset in any way. All Supporting Information files should come with a legend, listed at the end of the main article. Each figure and table file should not be larger than 10 MB, although video files may be larger. Prior to submission, please check the guidelines at:
http://authorservices.wiley.com/bauthor/suppmat.asp.

12. SUBMISSION OF MANUSCRIPTS
Manuscripts must be submitted online at:
http://mc.manuscriptcentral.com/ases/.
Authors must supply an email address as all correspondence will be by email.

General
All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
• Submissions must be double-spaced.
• All margins should be at least 30 mm.
• All pages should be numbered consecutively in the top right-hand corner, beginning with the title page.
• Do not use ‘Enter’ at the end of lines within a paragraph.
• Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
• Specify any special characters used to represent non-keyboard characters.
• Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for β (Greek beta).
• Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).
• Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process.

Covering Letter
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter.

The covering letter must also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified.

Authors must also state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Tokyo 2008). All investigations on human subjects must include a statement that the subject gave informed consent and patient anonymity should be preserved. Authors should declare any financial support or relationships that may pose conflict of interest.

Pre-acceptance English-language Editing
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. Visit our site to learn about the options. All services are paid for and arranged by the author. Please note using the Wiley English Language Editing Service does not guarantee that your paper will be accepted by this journal.

13. PROOFS
Corresponding authors must supply an email address to which correspondence can be emailed while their article is in production. Notification of the URL from where to download a Portable Document Format (PDF) typeset page proof, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated, otherwise, it may be signed off by the Editor or held over to the next issue. Acrobat Reader will be required in order to read the PDF. This software can be downloaded (free of charge) from the following Web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof.

14. OFFPRINTS
A PDF offprint of the online published article will be provided free of charge to the corresponding author, and may be distributed subject to the Publisher's terms and conditions. Paper offprints of the printed published article may be purchased if ordered via the method stipulated on the instructions that accompany the proofs.

15. COLOR FEE
Up to four color illustrations, if judged relevant and of good quality, will be published in print and online free of charge for each contribution. A charge of the fifth and subsequent color figures in print will be charged to the Contributor. Composite color photographs made up of smaller pictures are not accepted.

16. TRACKING MANUSCRIPTS
Before acceptance: Authors can track your manuscript's progress through the review process at: http://mc.manuscriptcentral.com/ases/.

After acceptance: Author Services enables authors to track their article, once it has been accepted, through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated emails at key stages of production so they do not need to contact the Production Editor to check on progress. For more details on online production tracking and for a wealth of resources, including FAQs and tips on article preparation, submission and more, visit:
http://authorservices.wiley.com/bauthor/.

17. EARLYVIEW
EarlyView articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. EarlyView articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of EarlyView articles means that they do not yet have volume, issue or page numbers, so EarlyView articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at: http://www.doi.org/faq.html.

18. THE JOURNAL ONLINE
For more information, visit the Journal home page: http://wileyonlinelibrary.com/journal/ases.
Visit Wiley’s web pages for submission guidelines and digital graphics standards: http://authorservices.wiley.com and http://authorservices.wiley.com/bauthor/illustration.asp

19. EDITORIAL OFFICE
ASES Editorial office
c/o Wiley Japan
Frontier Koishikawa Bldg., 4F,
1-28-1 Koishikawa, Bunkyo-ku,
Tokyo 112-0002, Japan
E-mail: ases@wiley.com
Tel: +81 3 3830 1256
Fax: +81 3 5689 7278 

SEARCH

SEARCH BY CITATION